22nd Century Group Inc (XXII)

[rightcoast1]

$XXII A reminder of the FDA’s briefing document to TPSAC prior to the committee’s review of XXII’s VLN MRTP application (February 18, 2020): “FDA’s preliminary scientific review of the application found that the … proposed claims are substantiated: there is about a 95% reduction in nicotine in the tobacco itself, the smoke it yields, and the nicotine that is absorbed when the product is smoked exclusively...Using [reduced nicotine content] cigarettes can reduce nicotine dependence.”

https://www.businesswire.com/news/home/20200218005321/en/FDA-Scientific-Advisory-Committee-Discusses-22nd-Century-Group’s-Reduced-Nicotine-Cigarettes